EcoDrugPlus

Atpase H+/k+ Transporting Subunit Beta

Ensembl ID : ENSOMYG00000063533
Gene Symbol: ATP4B
1 Cross references
183 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2a

Ensembl ID : ENSOMYG00000028700
Gene Symbol: ATP1A2A
1 Cross references
199 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 2a

Ensembl ID : ENSOMYG00000042865
Gene Symbol: ATP1A2A
1 Cross references
199 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2b

Ensembl ID : ENSOMYG00000029628
Gene Symbol: ATP1B2B
1 Cross references
198 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2b

Ensembl ID : ENSOMYG00000040789
Gene Symbol: ATP1B2B
1 Cross references
197 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3a

Ensembl ID : ENSOMYG00000029005
Gene Symbol: ATP1B3A
1 Cross references
230 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSOMYG00000019634
Gene Symbol: ATR
1 Cross references
197 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSOMYG00000062844
Gene Symbol: BRAF
1 Cross references
216 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSOMYG00000072108
Gene Symbol: BCL2
1 Cross references
170 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSOMYG00000038826
Gene Symbol: BCL2
1 Cross references
170 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSOMYG00000008424
Gene Symbol: BCL2L1
1 Cross references
221 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSOMYG00000043310
Gene Symbol: BCL2L1
1 Cross references
220 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).